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Abstract
The important and diverse biological functions of b-adrenergic receptors (bARs) have promoted the search for compounds
to stimulate or inhibit their activity. In this regard, unraveling the molecular basis of ligand binding/unbinding events is
essential to understand the pharmacological properties of these G protein-coupled receptors. In this study, we use the
steered molecular dynamics simulation method to describe, in atomic detail, the unbinding process of two inverse agonists,
which have been recently co-crystallized with b1 and b2ARs subtypes, along four different channels. Our results indicate that
this type of compounds likely accesses the orthosteric binding site of bARs from the extracellular water environment.
Importantly, reconstruction of forces and energies from the simulations of the dissociation process suggests, for the first
time, the presence of secondary binding sites located in the extracellular loops 2 and 3 and transmembrane helix 7, where
ligands are transiently retained by electrostatic and Van der Waals interactions. Comparison of the residues that form these
new transient allosteric binding sites in both bARs subtypes reveals the importance of non-conserved electrostatic
interactions as well as conserved aromatic contacts in the early steps of the binding process.
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Introduction
G protein-coupled receptors (GPCRs) represent one of the
largest protein families in mammals [1] and constitute 2%–3% of
the human proteome [2]. GPCRs transduce sensory signals of
external origin, such as photons, odors or pheromones, and
endogenous signals including biogenic amines, (neuro)peptides,
proteases, glycoprotein hormones and ions, into the cell. Thus,
these receptors are essential in cell physiology, and their
malfunction is commonly translated into pathological outcomes
[3]. As a result, GPCRs constitute one of the most important
pharmaceutical targets, as around 40% of prescribed drugs act
through this family of proteins [4]. These receptors feature a
common fold of seven transmembrane helices (TMs 1 to 7)
connected by three extracellular (ECLs 1 to 3) and three
intracellular (ICLs 1 to 3) loops [5], with an extracellular N-
terminus and an intracellular C-terminus. Extracellular regions are
very diverse in structure and amino acid composition, and in many
GPCRs, as glycoprotein hormone and peptide receptors in family
A or most receptors in families B and C, they are directly involved
in ligand binding [6]. While smaller ligands bind in a pocket
relatively buried within the TM bundle, they must also interact
with the extracellular regions in order to reach the binding site.
Understanding the molecular basis of ligand-receptor interactions
in the extracellular domains is of great importance, as they are
implicated in many aspects of receptor function, as ligand binding
[7] and specificity [8], allosterism [9] or receptor activation
[10,11]. Importantly, recent NMR data show ligand-specific
conformational changes in the extracellular surface of the b2-
adrenergic receptor (b2AR) [12].
While there is a vast amount of pharmacological, functional and
pathophysiological information about GPCRs deposited in spe-
cialized databases (e.g. IUPHAR-DB, at http://www.iuphar-db.
org), structural data of GPCRs is still scarce. Presently, only the
structures of eight Class A GPCRs (bovine and squid rhodopsins,
human b2-adrenergic, turkey b1-adrenergic, human A2A adeno-
sine (reviewed in [13,14,15]), human CXCR4 chemokine [16],
human dopamine D3 [17] and human histamine H1 [18]
receptors) are known. The availability of the structure of the
b1AR [19] and b2AR [20] represents a unique opportunity to
investigate the similarities and/or differences in the ligand entry
process between these closely related subtypes. While these
receptors have slightly different pharmacological properties [21],
they present a strong similarity in sequence and structure,
particularly in the TM bundle and orthosteric binding pockets
[19]. Thus, it is plausible to argue that extracellular regions can
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between subtypes. Previous theoretical studies, using random
acceleration molecular dynamics simulations, have suggested that
ligands access the orthosteric binding site of the b2AR mainly
through an opening at the extracellular surface [22]. Conversely,
ligand docking calculations in opsin located the paths for access/
egress between transmembrane helices [23]. This difference is due
to both the different architecture of the extracellular regions and
the different chemical nature of their respective ligands. While the
b2AR binding pocket is relatively exposed to the solvent, ECL 2
and the N-terminal of opsin cover the binding pocket, which form
a ‘‘plug’’ that prevents the access of the ligand from the
extracellular environment.
In this work, we have conducted a comparative analysis of the
process of ligand dissociation in b1 and b2ARs using the steered
molecular dynamics (SMD) simulation method [24]. SMD has
been very successful in the study of dissociation reactions of
several small-molecules/protein complexes through application
of external forces on nanosecond time scales [25,26,27,28], and
is particularly useful to describe the interactions occurring in the
binding/unbinding of ligands [25]. Our results suggest that both
receptors have two putative ligand entry channels located at the
extracellular region, discarding the entry channels located
between the transmembrane segments that lead to the lipid
environment. By monitoring the forces and energies of the
ligand-dissociation along these extracellular channels in both
bAR structures, we have identified for the first time two
secondary binding pockets in the extracellular region of the
receptors. In addition, we discuss the importance for the ligand
exit/entry process of non-conserved charged residues and
conserved aromatic interactions shared by the two entry
channels.
Results
Ligand entry/exit channels in b1 and b2 adrenergic
receptors
Using the skeleton search algorithms implemented in the
CAVER program [29], we explored routes that connect the
buried orthosteric binding pocket to the extracellular surface in
the structures of the human b1AR and b2AR. Figure 1 displays
two entry channels identified in each receptor, located between
TMs 3, 5, 6 and 7 (C1) and TMs 1, 2, 3 and 7 (C2). These
channels are separated from each other by charged residues in
ECLs 2 and 3; D217 and D356 in b1AR (Figure 1a) and D192
and K305, forming a salt bridge, in b2AR (Figure 1b). These
Figure 1. Extracellular molecular surfaces of the b1AR (panel a) and b2AR (panel b), embedded in a lipid bilayer (in yellow). The
electrostatic potential was calculated using the program APBS with nonlinear Poisson-Boltzmann equation and contoured at 610 kT/e (negatively
and positively charged surface areas in red and blue, respectively). The accessible channels (C1 and C2) identified by CAVER are depicted as green
wires. D217/D356 in b1AR (panel a) and the salt bridge D192/K305 in b2AR (panel b) are represented by circled 2 and + symbols. Panel c displays the
extraction vectors along the four channels (C1 to C4) at the end of the equilibration run. The b2AR ribbon structure is colored as follows: TM1 (grey),
TM2 (yellow), TM3 (red), TM4 (black), TM5 (green), TM6 (blue), TM7 (cyan), and helix 8 (red). Carazolol is shown in white sticks. Pictures were prepared
using PyMOL (http://www.pymol.org/).
doi:10.1371/journal.pone.0023815.g001
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amino acids, confer a negative electrostatic potential to both
channels, which suggests the existence of an electronegative
funnel to attract positively charged ligands into the orthosteric
binding site of beta adrenoceptors [30]. On the other hand, the
entrance/exit channels for retinal in rhodopsin have been
proposed to occur through the lipid bilayer, via two openings
located between TMs 1 and 7, and TMs 5 and 6, respectively
[23]. While CAVER does not detect these alternative channels in
the bAR structures, in order to further assess their possible
relevance, we identified these two channels on the structure of the
ligand-free apoprotein opsin (PDB entry 3CAP [31]) and mapped
them onto the bAR structures by coordinate superimposition (C3
and C4 in Figure 1c).
Channel route preferences for ligand dissociation
To study the process of ligand release from b1AR and b2AR
orthosteric binding pockets, we performed SMD simulations of the
antagonist-receptor complexes embedded in a model lipid bilayer
(see Methods). Ten nanoseconds of equilibration were performed
to obtain constant values of energy, cell volume and lipid density.
The root mean square deviation (rmsd) of the protein backbone
atoms from the initial coordinates during equilibration stabilizes
rapidly to a value in the vicinity of 2.0 A ˚ (Figure S1). Following
this equilibration period, steered forces were applied to both
ligands along the four calculated channels (C1 to C4 in Figure 1c).
Figure S2 displays representative force profiles of the pulling
experiments of cyanopindolol (Figure 2a) and carazolol (Figure 2b)
along extracellular C1 (black) and C2 (blue) and lipid C3 (red) and
C4 (yellow) channels. The initial force peaks to remove ligands
from the orthosteric binding site via extracellular C1 or C2
channels were on average ,600 pN, a typical value in ligand
diffusion SMD experiments [26,32]. On the contrary, pulling the
ligands through the proposed rhodopsin channels (C3 and C4 in
Figure 1c), required forces two-fold larger than for the extracel-
lular routes. These results strongly suggest that, in bARs, the
transit of molecules through the lipidic phase, via TMs 1 and 7 or
TMs 5 and 6, is not favored compared to the extracellular routes.
Consequently, the C3 and C4 channels were not included in the
rest of the analysis.
Residues implicated in ligand-receptor interactions
during dissociation
Figures 2 and 3 display the potential of mean force (PMF) and
representative force profiles (insets) of the pulling experiments of
cyanopindolol (Figures 2a and 3a) and carazolol (Figures 2b and
3b) along the extracellular C1 and C2 channels. In all cases, small
fluctuations were observed in receptor structures during ligand
extraction, which were in similar ranges to the rmsd values of the
equilibration runs (data not shown). These results indicate that
selected velocities, force constants, and extraction vectors were
adequate to achieve smooth ligand releases. Thus, no steric clashes
occur between molecules and receptors during dissociation.
Horizontal bars in the insets of Figures 2 and 3 represent time
periods of relatively strong ligand-receptor interaction during
dissociation. Positive slopes in force profiles characterized these
periods. Clearly, disruption of the initial interactions between the
ligands and orthosteric binding site residues, which mainly include
the electrostatic interaction with D
3.32 and hydrogen bonds with
N
7.39 and S
5.42 (superscript numbers correspond to the Ballesteros
& Weinstein general numbering scheme [33]), requires a maximal
force (ramp symbols in the force insets). After this primary
unbinding event (,0.5 ns), forces fall as the ligands displace
further from the orthosteric binding site towards the solvent
through the exit channels. Then, subsequent regions of increasing
forces indicate secondary interaction sites along the channels.
The extraction of cyanopindolol through channel C1 in b1AR
reveals two major retention events, (Figure 2a). In an initial step at
,1.2 ns, cyanopindolol is stabilized by an ionic interaction
between the protonated amine of the ligand and D217 in ECL2
and a hydrogen bonding interaction between the b-OH group and
D356
7.32 (Figure 4a). Later, in the final steps of its movement
toward the extracellular solvent (,2.0 ns), increasing forces are
required to break a salt bridge between E205 in ECL2 and R351
in ECL3 (also shown in Figure 4a), in order to allow the ligand
escape. Conversely, the extraction of carazolol from b2AR through
C1 is characterized by a single retention site at ,1.2 ns (Figure 2b).
At this point, the protonated amine of the ligand interacts with
D192 in ECL2 and the b-OH group with N301 in ECL3
(Figure 4b). Table 1 lists residues in the vicinity of the ligands
during the dissociation process that form this extraction channel.
Figure 2. PMF and force profiles of ligand extraction along the extracellular channel C1. Panel a, dissociation of cyanopindolol from b1AR.
Panel b, dissociation of carazolol from b2AR. The star symbols correspond to the snapshots depicted in Figure 5. The statistical error in the PMF data is
shown in bars. Inset figures display representative force profiles of the repeated trajectories. The force simulation data is shown in grey and
smoothed to a black line. Horizontal bars denote regions with positive slope in the force profile.
doi:10.1371/journal.pone.0023815.g002
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two retention sites at ,0.9 and ,1.5 ns in both adrenoceptors
(Figure 3). Initially, the protonated amine of cyanopindolol or
carazolol interacts with either D217 or D192 in ECL2 of b1- and
b2- receptors, respectively (Figures 5a and 5b). The second barrier
corresponds to Van der Waals attractive forces between the
aromatic moieties of the ligands and bulky residues at positions
2.64, 2.65, 3.28, 7.36, 7.39 and 7.40 in TMs 2, 3 and 7
(summarized in Table 1). In the final steps of the simulations the
ligands drifted apart from the receptors with no further retention
and the forces decays to zero.
Physico-chemical nature and sequence conservation of
the entry channels
In both b1- and b2AR, the two identified extracellular channels
of ligand entry/exit differ strongly in their physico-chemical
properties, as channel C1 is strongly hydrophilic (10 polar/
charged residues out of 13) whereas C2 is mainly hydrophobic (7
apolar/aromatic residues out of 10) (summarized in Table 1).
Despite this overall similarity between b1AR and b2AR in the
fundamental nature of the ligand entry/exit routes, sequence
conservation in these regions strongly differs between receptors.
Comparison of conserved residues reveals that the sequence
Figure 3. PMF and force profiles of ligand extraction along the extracellular channel C2. Panel a, dissociation of cyanopindolol from b1AR.
Panel b, dissociation of carazolol from b2AR. The star symbols correspond to snapshots depicted in Figures 6. See legend of Figure 2 for details.
doi:10.1371/journal.pone.0023815.g003
Figure 4. Secondary binding pockets identified in the C1 channel. Panel a shows the cyanopindolol/b1AR complex and panel b shows the
carazolol/b2AR complex. The orientation of these views are the same as in Figures 1a and 1b. Circles show the approximate locations of channels C1
and C2. Ligands are shown in green sticks, and side chains within 3 A ˚ of the ligands are shown in white sticks. Solvent-accessible surfaces of aromatic
F359/Y308
7.35 and F218/F193 residues are displayed in orange. Panel c depicts the sequence alignment of this region between human bARs. Residues
along the extraction trajectories that interact with ligands are highlighted in black, and non-conserved residues are showed in a smaller size.
doi:10.1371/journal.pone.0023815.g004
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b2ARs.
C1 BW b1AR b2AR b3AR
ECL2 - S203 H178 A182
- E205 E180 E185
- D217 D192 A197
- F218 F193 F198
- V219 F194 A199
- T220 T195 S200
TM5 5.36 R222 Q197 M202
TM6 6.55 N344 N293 N312
6.58 K347 H296 R315
ECL3 - R351 D300 P320
- E352 N301 S321
- D356 K305 G325
C2
TM2 2.64 I118 H93 L97
2.65 V119 I94 A98
TM3 3.28 W134 W109 W113
ECL2 - D217 D192 A197
- F218 F193 F198
TM7 7.36 V360 I309 L329
7.39 N363 N312 N332
7.40 W364 W313 W333
ECL3 - D356 K305 G325
The corresponding residues in the b3AR subtype are also included for comparison. The generic numbering of Ballesteros & Weinstein (BW) is shown for TM amino acids.
Numbering of residues corresponds to the human annotated sequences UniProtKB/Swiss-Pro entries: b1AR (P08588), b2AR (P07550) and b3AR (P13945), and the residues
that form part of both channels are shown in boldface.
doi:10.1371/journal.pone.0023815.t001
Figure 5. Secondary binding pockets identified in the C2 channel. Panel a shows the cyanopindolol/b1AR complex and panel b shows the
carazolol/b2AR complex. See legend of Figure 4 for details.
doi:10.1371/journal.pone.0023815.g005
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13 residues), while in C2 is 70% (7 out of 10 residues, considering
Ile and Val as nearly equivalent).
Characterization of intermediate binding sites
The potential of mean force along extraction coordinates was
calculated using the second cumulant expansion of Jarzynski’s
expression by sampling the work from repeated trajectories [34].
PMF values between starting and ending points were used to
estimate free energy changes of dissociation reactions. The free
energy cost of moving the ligand from the binding site crevice to
bulk water is 7.0 or 6.0 kcal/mol for b1AR, and 5.6 or 6.9 kcal/
mol for b2AR, via C1 or C2 channels, respectively (Figures 2 and
3). Clearly, these positive values indicate that receptor-bound
states are more favorable in both receptors. Obviously, initial
(ligand bound to receptor) and final (ligand in bulk water) states of
the SMD simulations, via C1 or C2 channels, are the same,
allowing us to estimate the procedure error. The difference in
energy of 1.0 and 1.3 kcal/mol, observed for b1AR and b2AR,
respectively, between channels C1 and C2, are considered small
errors given the complexity of the ligand-receptor-lipid bilayer
system. Although no energy minimum was found in the free
energy profile, we observed a decrease in the PMF slopes in a
narrow region, at distance of ,9t o1 5A ˚ from the orthosteric
binding sites in all experiments (black stars in Figure 2 and 3).
These secondary binding pockets correlate with the retention
regions identified previously in the C1 and C2 channels and
comprise residues located in ECL2 and ECL3, and in the
outermost solvent exposed area of TMs (Figures 4 and 5). The free
energy cost to move cyanopindolol from the orthosteric binding
pocket of b1AR to the secondary binding pocket situated in C1
(2.9 Kcal/mol) is comparable to the value found for the C2
channel (3.2 kcal/mol) and both are located at a distance of
,9.0 A ˚ from the orthosteric binding site. In contrast, the
secondary binding pocket in C2 (5.7 kcal/mol) of b2AR is less
favorable than in the C1 channel (3.1 kcal/mol) and is located at
,15 A ˚ from the orthosteric binding site. In this particular case,
additional energy is required to displace the bulky carbazole group
of carazolol through the bulky H
2.64,I
2.65,W
3.28 and I
7.36 residues
in TMs 2, 3 and 7 (Figure 5b).
Discussion
In this work, we have explored the possible exit routes of
ligands in the structures of human b1AR and b2AR using SMD
simulations. We have found that both receptors have two well-
defined access channels from the extracellular side (C1 and C2 in
Figure 1). While we explicitly simulate the process of ligand
dissociation, the relatively rigid arrangement of the extracellular
domains of the receptors strongly suggests that the same channels
are also used in the process of ligand entry. During dissociation,
ligands are retained in the boundary with the extracellular
solvent (,9–15 A ˚ from the orthosteric binding site, Figures 4 and
5), as evidenced by the decrease in the PMF slopes and larger
force values during the SMD experiments (Figure 2 and 3, black
stars). We suggest that these retention sites serve as secondary
binding pockets during ligand entry. Interestingly, the access
channels differ strongly in their physicochemical properties and,
particularly, in their degree of sequence conservation (38%
identity in C1 vs. 70% identity in C2). However, our simulations
produce similar PMF profiles for C1 and C2 in both receptors
and, thus, both routes may serve indistinguishably for the entry
and exit of inverse agonists. Importantly, all the TM residues
identified in our study have been experimentally found to be
involved in ligand interactions for bARs or/and other GPCRs:
2.64 [35,36], 2.65 [37,38], 3.28 [39,40], 5.36 [41], 6.55 [42],
6.58 [43,44], 7.35 [38,45], 7.36 [46], 7.39 [47] and 7.40 [48].
Also, as the two channels are connected through the orthosteric
binding site, we cannot rule out the possibility that ligands could
use one route for entry and the other for exit, in the same
manner as proposed for the uptake and release of retinal in
rhodopsin [23].
Charged residues in ECLs 2 and 3 separate the C1 and C2
channels from each other (Table 1). These residues are D217 and
D356 in b1AR and D192 and K305, forming a salt bridge, in
b2AR. Importantly, D217 in b1AR and the homologous D192 in
b2AR are involved in hydrogen bonding interactions with the
protonated group of cyanopindolol and carazolol, respectively,
during dissociation via both the C1 and C2 channels (see Figures 4
and 5). We hypothesize that these common negatively charged
side chains play an important role to attract the ligand to the
channels, and to provide the energy to partially desolvate the
ligand. Clearly, extracellular ligands must be transferred from the
extracellular aqueous environment to the binding site crevice in
the TM domain, away from bulk water. Thus, a crucial
contribution to the ligand-receptor binding affinity is the
desolvation of the ligand. Interestingly, the corresponding residues
in b3AR are non-bulky hydrophobic amino acids, A197 and
G325. These remarkable differences are most likely translated into
a different pattern of ligand entry in these receptors.
In addition, the C1 and C2 channels are also delineated by
F218 in b1AR and F193 in b2AR, located in ECL2, and F359
7.35
in b1AR and Y308
7.35 in b2AR, located in TM7 (depicted by
solvent surfaces in Figures 4 and 5). Previous MD simulations on
b2AR have suggested that F193 is able to achieve different
conformations [12,22]. These features were reproduced in our
simulations, as we observed a rotation of both the F218 and F193
side chains (black traces in Figures 6a (b1AR, ligand exit through
C1), 6b (b1AR, ligand exit through C2), 7a (b2AR, ligand exit
through C1) and 7b (b2AR, ligand exit through C2) that parallels
the transition of the ligands from the TM bundle into the solvent.
However, in contrast with previous works, we observed that the
conformational changes of F218 and F193 in ECL2 correlate with
an increase in the number of water molecules around ligands
during dissociation (grey contour in Figures 6a, 6b, 7a and 7b).
Based on this observation, we suggest a novel role for these
residues: we hypothesize that in the process of ligand entry F218
and F193 serve as a floodgate by removing the water solvent shell
around the compounds during binding.
The extraordinary variability in length and amino acid
composition of the extracellular loops across the GPCR super-
family generates a wide recognition space for ligands with very
diverse chemical scaffolds. For instance ECL 2 of rhodopsin,
formed by two b-strands, buries the binding site from the
extracellular environment, whereas ECL 2 of CXCR4, also
formed by two b-strands, fully exposes the binding site to the
extracellular environment. In contrast, a helical segment forms
ECL 2 of the b1- and b2- adrenergic receptors. This a-helix is
probably not conserved in the other members of the biogenic
amine receptor family, as it was not found in the structure of the
dopamine D3 receptor. It was recently shown that ECLs 2 and 3
of the b2-adrenergic receptor exist in three distinct conformations
depending on the type of ligand bound to the TM core (neutral
antagonists, agonists, or inverse agonists) [12,22]. Thus, this
extracellular domain of the receptor plays a key role in receptor
activation. We hypothesize that small molecules binding to these
secondary-binding pockets, in the extracellular domain, might act
as allosteric modulators.
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Molecular models and identification of ligand access
channels
The high-resolution crystal structures of the b1AR [19] and
b2AR [20] were obtained from the Protein Data Bank (PDB
entries 2VT4 and 2RH1 respectively). MODELER [49] was used
to transform the starting coordinates of the turkey b1AR
(UniProtKB: P07700) to the human sequence (UniProtKB:
P08588). It is important to note that major differences between
turkey and human sequences are present in the N- and C-
terminal regions (e.g. human b1AR have an N-terminal domain
17 residues longer). The notation of the b1AR amino acids in the
manuscript corresponds to the human sequence. CAVER [29]
was used to determine channels connecting the ligand binding
site to the extracellular surface in snapshot structures (every
0.5 ns) along the equilibration period (see below). The initial state
for cavities search was at the center of mass of the ligands and a
grid spacing of 0.5 A ˚ was used. This approach leads to the
identification of two channels in both receptors (C1 and C2 in
Figure 1). In addition, we include two inter-helical channels (C3
and C4) calculated by the same procedure for the GPCR opsin
[23] and superimposed onto the bARs coordinates. These
‘‘rhodopsin-like’’ channels, however, were not detected by
CAVER in the bARs structures.
Molecular dynamics (MD) simulations
The b1AR and b2AR human receptors in ligand bound
conformation and nine internal water molecules in the P
6.50/
D
2.50/N
7.49/Y
7.53 environment [50] were embedded in a
pre-equilibrated lipid bilayer consisting of 282 molecules of
1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylcholine (POPC).
These crystallographic water molecules did not displace signifi-
cantly from their starting positions during the simulations (data
not shown). Electroneutrality of the system was achieved by
adding chloride ions to fulfill a net charge of zero; then,
additional sodium and chloride ions were added to a final
concentration of 0.1 mol/L. Simulations were carried out using
the NAMD version 2.7 MD package [51] using the TIP3 water
model and the CHARMM27 all-hydrogen force field [52].
Atomic charges for carazolol and cyanopindolol were calculated
with HF/6-31G* and RESP [53], and compared against the
corresponding atom types in the CGenFF [54]. In all cases, we
only observed small differences in values, while the signs of the
charges were always maintained. Long-range electrostatic
interactions were calculated using the particle mesh Ewald
(PME) method [55]. Initial coordinates were optimized by energy
minimization. After geometry optimization, the temperature of
the systems was raised in 30.000 steps by temperature
reassignment method followed by 10 ns of equilibration at
300 K and constant pressure.
Steered molecular dynamics (SMD) simulations
The SMD method implemented in NAMD [24] was used to
simulate ligands dissociation. The directions of the applied forces
(reaction coordinate) were vectors with origin in the center of mass
of the ligands and having minimal standard deviation from the
path graph nodes defined by CAVER. SMD simulations were
performed at constant velocity of 10 A ˚/ns and the spring constant
was set to 250 pN/A ˚. These parameters were similar to those used
previously in biological systems and sufficient to ensure that the
work distribution is Gaussian [56]. Each trajectory was carried out
until the ligands were displaced towards the receptor surface, and
was repeated 6 times. The pulling force F at time t was calculated
Figure 7. Number of water molecules at a distance of 3 A ˚ from
carazolol (grey solid contour) and x1 torsion angle of F193
(black lines) from selected b2AR SMD trajectories through
channels C1 (panel a) and C2 (panel b).
doi:10.1371/journal.pone.0023815.g007
Figure 6. Number of water molecules at a distance of 3 A ˚ from
cyanopindolol (grey solid contour) and x1 torsion angle of
F218 (black lines) from selected b1AR SMD trajectories through
channels C1 (panel a) and C2 (panel b).
doi:10.1371/journal.pone.0023815.g006
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F(t)~k(vt{(~ r r(t){~ r r0):~ n n) ð1Þ
where k is the spring constant, v is the constant velocity of pulling,
r0 and r(t) are the ligand center of mass position at initial and
current time t respectively, ~ n n is the direction of the pulling vector.
The potential of mean force (PMF) along the reaction coordinate
was calculated by the second-order cumulant expansion of the
irreversible work measurements [34] according to:
W(t)~v
ðt
0
F(t)dt ð2Þ
PMF~SWT{
1
2kBT
SW2T{SWT
2   
ð3Þ
where ÆWæ is the mean work averaged from the six trajectories, kB
is Boltzmann’s constant and T is the bulk temperature.
The Jarzynski’s equality applied in this study is relative easy to
implement compared to other free energy methods such as
umbrella sampling. However, it is not exempt of the inaccuracies
inherent to the insufficient sampling of the configuration space
[57]. Thus, we have only used the PMF profiles as a guideline for
the identification of residues involved in interaction with the
ligands during the extraction process. Specifically, we do not to
aim to compare the theoretical energy values with experimental
binding affinities.
Supporting Information
Figure S1 Rmsd values of the backbone atoms of b1AR
(a) and b2AR (b) along the trajectories of the MD
equilibrium simulations of the receptor-membrane
systems.
(TIF)
Figure S2 Representative force profiles of ligand ex-
traction along the C1–C4 channels. Panel a corresponds to
the cyanopindolol/b1AR complex and panel b corresponds to the
carazolol/b2AR complex. C1 and C2 correspond to extracellular
routes whereas C3 and C4 correspond to routes that lead to the
membrane core.
(TIF)
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